Skip to content

Trifluperidol

NERVOUS SYSTEM

Also known as: psicoperidol, trifluoperidol, trifluperol, triperidol

ATC N05AD02

Data last refreshed: (DrugCentral release 2024-11-01)

Key facts

Trifluperidol is a drug catalogued in DrugCentral. DrugCentral lists 7 molecular targets, including ERG2, DRD2 and DRD4.

  • Molecular targets: ERG2, DRD2, DRD4 and Sigmar1 (7 listed in DrugCentral).
  • ATC code: N05AD02 (Butyrophenone derivatives).
  • Molecular formula: C22H23F4NO2; molecular weight 409.43 g/mol.

Mechanism & targets

Molecular targets (7)

TargetGeneActionActivity
C-8 sterol isomeraseERG2unknownKi 9.82
D(2) dopamine receptorDRD2unknownKi 9.70
D(4) dopamine receptorDRD4unknownKi 9.46
Sigma non-opioid intracellular receptor 1Sigmar1unknownKi 9.10
Sigma non-opioid intracellular receptor 1SIGMAR1unknownKi 9.08
D(3) dopamine receptorDRD3unknownKi 8.46
3-beta-hydroxysteroid-Delta(8),Delta(7)-isomeraseEBPunknownKi 6.78

ATC classification

ATC codeTherapeutic hierarchy
N05AD02NERVOUS SYSTEM › PSYCHOLEPTICS › ANTIPSYCHOTICS › Butyrophenone derivatives

Chemical structure

Full physicochemical, ADMET and 3D-structure analysis of Trifluperidol is on its molecule page.

Molecular formulaC22H23F4NO2
Molecular weight409.43 g/mol
CAS number749-13-3
InChIKeyGPMXUUPHFNMNDH-UHFFFAOYSA-N
PubChem CID5567
OC1(CCN(CCCC(=O)C2=CC=C(F)C=C2)CC1)C1=CC(=CC=C1)C(F)(F)F

Frequently asked questions

Answers are generated from the structured data on this page, not written by hand.

How does Trifluperidol work?

Its molecular targets in DrugCentral include ERG2, DRD2, DRD4 and Sigmar1.

What is the chemical formula of Trifluperidol?

Trifluperidol has the molecular formula C22H23F4NO2 and a molecular weight of 409.43 g/mol.

Browse: all drugs starting with T · drug guides by category · protein targets A–Z.

Sources

How this page is built: methodology · editorial policy & corrections.

For research and educational use only — not medical advice. This page is compiled automatically from public databases. It is not written or reviewed by a clinician. Do not start, stop or change any treatment based on it; consult a qualified healthcare professional. Spotted an error? See our corrections policy or email hello@molforge.ai.

Quick facts

Status—
First approval—
Agency—
Targets7
Indications0
FormulaC22H23F4NO2
DrugCentral ID2741
Interactive profile